期刊文献+

小檗碱改善高糖诱导血管内皮细胞和微血管内皮细胞损伤 被引量:7

Berberine Improves High Glucose-induced Damage to Vascular Endothelial Cells and Microvascular Endothelial Cells
下载PDF
导出
摘要 目的:探讨小檗碱对高糖引起的人脐静脉血管内皮细胞(HUVEC)和人心脏微血管内皮细胞(HCMEC)损伤的保护作用。方法:采用含5mM葡萄糖的完全培养基培养的HUVEC和HCMEC为对照组;含30、50、100、200mM葡萄糖的完全培养基培养的HUVEC和HCMEC为各高糖组;含100mM葡萄糖和0.01、0.1、1μM小檗碱的完全培养基培养的HUVEC和HCMEC为各小檗碱组,各组处理24h和48h后应用MTT法检测细胞活力。应用诱导型一氧化氮合酶(iNOS)试剂盒检测HUVEC细胞iNOS活性。结果:与对照组比较,30、50、100、200mM葡萄糖浓度依赖性引起HUVEC和HCMEC的细胞活力依次下降(P<0.05)。同组细胞处理48h与24h比较,随着作用时间的延长细胞活力降低越明显。0.01μM、0.1μM和1μM小檗碱组较100mM高糖组细胞活力在一定程度上有所改善(P<0.05)。与对照组比较,高糖组HUVEC的iNOS活性增加(P<0.01),小檗碱组较高糖组iNOS活性明显降低(P<0.01)。结论:30-200mM高糖可造成HUVEC和HCMEC损伤,小檗碱对损伤有一定的保护作用,其作用和下调iNOS活性有关。 Objective:To investigate the ameliorative effects of berberine on high glucose-induced damage of human umbilical vein endothelial cells(HUVEC)and human cardiac microvascular endothelial cells(HCMEC).Method:HUVEC and HCMEC were cultured in complete medium containing 5 mM glucose as control group,HUVEC and HCMEC were cultured in complete medium containing 30,50,100 and 200 mM glucose for each high glucose group.HUVEC and HCMEC were cultured in complete medium containing 100 mM glucose and 0.01,0.1,1μM berberine were each berberine group.After 24h and 48h treatment,the cell viability was measured by MTT assay.The iNOS activity of HUVEC was detected by inducible nitric oxide synthase(iNOS)kit.Results:Compared with control group,30,50,100 and 200mM glucose induced HUVEC and HCMEC cell viability decreased in a dose-dependent manner(P<0.05).Compared with 24h in the same group,the cell viability decreased with the prolongation of the time.The cell viability of 0.01μM,0.1μM and 1μM berberine group was improved to some extent compared with 100 mM high glucose group(P<0.05).Compared with the control group,the iNOS activity of HUVEC in 100mM glucose group was increased(P<0.01),and the activity of iNOS in berberine group was significantly lower than that in high glucose group(P<0.01).Conclusion:High glucose can cause HUVEC and HCMEC
作者 侯聪聪 梁红玉 赵丽丽 赵丁 HOU Cong-cong;LIANG Hong-yu;ZHAO Li-li;ZHAO Ding(School of Pharmacy,Hebei Medical University,Shijiazhuang 050017,China)
出处 《微循环学杂志》 2018年第1期7-11,共5页 Chinese Journal of Microcirculation
基金 河北省应用基础计划重点基础研究项目(17967753D)
  • 相关文献

参考文献4

二级参考文献80

  • 1傅重洋,洪光祥.血管内皮生长因子对神经系统血管再生与神经营养作用研究进展[J].国外医学(骨科学分册),2005,26(5):280-283. 被引量:12
  • 2刘声远.糖尿病血管病变机制与防治进展[J].微循环学杂志,2006,16(4):3-6. 被引量:15
  • 3侯宁宁,王朝迅,雒瑢,贾红蔚,邱明才.STZ-糖尿病大鼠小肠动力与肠神经胆碱能和氮能神经元关系的研究[J].天津医科大学学报,2007,13(2):165-167. 被引量:5
  • 4Yao J,Kong W,Jiang J.Learning from berberine:Treating chronic diseases through multiple targets[J].Sci China Life Sci,2013,57:1-6.
  • 5Baccari MC,Iacoviello C,Calamai F.Nitric oxide as modulator of cholinergic neurotransmission in gastric muscle of rabbits[J].Am J Physiol,1997,273(2):456-463.
  • 6Belaia A,Lefebvre RA,Burnstock G.Motor activity and neurotransmitter release in the gastric fundus of streptozotocin-diabetic rats[J].European Journal of Pharmacology,1991,194(3):225-234.
  • 7Cameron NE,Cotter MA.Pro-inflammatory mechanisms in diabetic neuropathy:focus on the nuclear factor kappa B pathway[J].Curr Drug Targets,2008,9(1):60-67.
  • 8Kong W,Wei J,Abidi P,et al.Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J].Nat Med,2004,10(12):1 344-1 351.
  • 9Ren LM,Zhuo YJ,Hao ZS,et al.Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats[J].Journal of Ethnopharmacology,2013,150(3):1 128-1 136.
  • 10Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang J D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med, 2004, 10:1344-1351.

共引文献59

同被引文献107

引证文献7

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部